The Regulatory Accountability Act of 2017 - Implications for FDA Regulation and Public Health.

The article discusses the Regulatory Accountability Act of 2017 which is passed by the U.S. Congress to reverse the increasing volume of regulatory requirements related to federal health policy. It mentions the revision of the 1946 Administrative Procedure Act that set ground rules for federal agency regulation. It notes the draft guidance issued by the U.S. Food and Drug Administration that allow any person to clarify governmental requirements and update outdated rules.